Foshan Stomatology Hospital and School of Medicine, Foshan University, Foshan 528000, Guangdong, China.
Department of Respiratory and Critical Care Medicine, Peking University Shenzhen Hospital, Futian District, Shenzhen 518036, Guangdong, China.
Aging (Albany NY). 2022 Apr 22;14(8):3446-3463. doi: 10.18632/aging.204022.
Lymphoma is accompanied by the impairment of multiple immune functions. Cytokines play an important role in a variety of immune-related functions and affect the tumor microenvironment. However, the exact regulatory mechanisms between them remain unclear. This study aimed to explore the cytokines expression and function in Hodgkin's lymphoma (HL), diffuse large B-cell lymphoma (DLBCL), and mantle cell lymphoma (MCL). We performed a transcriptome integration analysis of 14 lymphoma datasets including 240 Hodgkin's lymphoma, 891 diffuse large B-cell lymphoma, 216 mantle cell lymphoma, and 64 health samples. The results showed that multiple immune functions and signal pathway damage were shared by all three types of lymphoma, and these functions were related to cytokines. Furthermore, through co-expression network and functional interaction network analysis, we identified CXCL14 as a key regulator and it affects cell chemotaxis and migration functions. The functional experiment showed that CXCL14 knockdown inhibited cell migration in MCL cell lines. This study suggested that high expression of CXCL14 may aggravate MCL via promoting cell migration. Our findings provide novel insights into the biology of this disease and would be helpful for the pathogenesis study and drug discovery of lymphomas.
淋巴瘤伴随着多种免疫功能的损伤。细胞因子在多种免疫相关功能中发挥重要作用,并影响肿瘤微环境。然而,它们之间的确切调节机制尚不清楚。本研究旨在探讨霍奇金淋巴瘤(HL)、弥漫性大 B 细胞淋巴瘤(DLBCL)和套细胞淋巴瘤(MCL)中的细胞因子表达和功能。我们对包括 240 例霍奇金淋巴瘤、891 例弥漫性大 B 细胞淋巴瘤、216 例套细胞淋巴瘤和 64 例健康样本的 14 个淋巴瘤数据集进行了转录组整合分析。结果表明,三种类型的淋巴瘤均存在多种免疫功能和信号通路损伤,这些功能与细胞因子有关。此外,通过共表达网络和功能相互作用网络分析,我们确定 CXCL14 是一个关键调节剂,它影响细胞趋化和迁移功能。功能实验表明,CXCL14 敲低抑制了 MCL 细胞系的迁移。本研究表明,CXCL14 的高表达可能通过促进细胞迁移而加重 MCL。我们的研究结果为该疾病的生物学特性提供了新的见解,有助于淋巴瘤的发病机制研究和药物发现。
Int J Mol Sci. 2023-10-11
Clin Cancer Res. 2018-4-17
Biochem Biophys Res Commun. 2018-12-12
Mol Hum Reprod. 2021-2-5
Cardiovasc Res. 2021-2-22
Technol Cancer Res Treat. 2019-1-1
Science. 2018-3-23